Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AEOLUS PHARMACEUTICALS, INC. (AOLS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-16Sep-30-15Sep-30-14Sep-30-13Sep-30-12Sep-30-11Sep-30-10Dec-31-09
   10-K10-K10-K10-K/A10-K10-K/A10-K10-K
Revenues   [+]2.13.19.63.97.34.80.00.0
            Revenue growth  -33.3%-67.7%145.2%-46.1%51.3% -100.0% 
Cost of goods sold  5.35.79.76.69.78.70.00.0
Gross profit  -3.3-2.6-0.1-2.7-2.4-3.90.00.0
            Gross margin  -157.7%-84.4%-0.8%-68.7%-32.5%-80.9%  
Selling, general and administrative   [+]2.62.43.44.13.84.62.01.3
Research and development  2.93.57.03.46.55.11.70.7
EBITDA   [+]   -2.7-2.4-3.9-3.6 
            EBITDA margin  -157.7%-84.4%-0.8%-68.5%-32.4%-80.8%  
Depreciation and amortization     0.00.00.00.0 
EBIT   [+]-3.3-2.6-0.1-2.7-2.4-3.9-3.6-2.0
            EBIT margin  -157.7%-84.4%-0.8%-68.7%-32.5%-80.9%  
Interest expense, net   [+]0.30.0   0.00.90.4
Other income (expense), net   [+]0.00.00.0-0.54.14.2-21.30.1
Pre-tax income  -3.6-2.6-0.1-3.21.70.3-25.9-2.3
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate      0.1%0.7%0.0%0.0%
Net income  -6.0-2.6-0.1-3.20.90.3-25.9-2.3
            Net margin  -291.1%-84.5%-0.8%-81.7%11.7%6.2%  
   
Basic EPS   [+]($0.04)($0.02)($0.59)($0.03)$13.90$5.03($526.32)($66.00)
Diluted EPS   [+]($0.04)($0.02)($0.59)($0.03)$12.05$5.03($0.53)($66.00)
   
Shares outstanding (basic)   [+]148.7135.90.1106.60.10.10.00.0
Shares outstanding (diluted)   [+]148.7135.90.1106.60.10.149.20.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy